What struck me, however, was that Aileron holds patent rights to the stapled technology from Harvard University and its associated Dana Farber Cancer Institute. So now creating a patent monopoly, granted according to the constitution to individuals ostensibly to encourage innovation, becomes a way to make the university richer than it already is. Harvard is the same place that lost millions from its fat endowment when its then president Larry Summers began giving directions as to how it was to be invested and guessed wrong. Aileron will get a potential minimum gain of $25 million and a maximum of $1.1 billion if Aileron's projections work out. The article doesn't tell us what Harvard gets, beyond the original patent license fee of an undisclosed amount. Or whether the original research was funded by Federal Government research grants as is common or what the individual scientists involved get. A lot seems to be missing from this story.